| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |